As costs of cancer care rise, the importance of documenting value in oncology increases. Proton beam radiotherapy (PBT) has the potential to reduce toxicities in cancer patients, but is relatively expensive and unproven. Evaluating quality of life (QOL) and patient-reported outcomes (PROs) is essential to establishing PBT’s “value” in oncologic therapy. The goal of this systematic review was to assess QOL and PROs in patients treated with PBT.

中文翻译：

---

质子放射治疗后的生活质量和患者报告的结果：系统评价

随着癌症治疗成本的上升，记录肿瘤学价值的重要性也随之增加。质子束放射治疗（PBT）有可能减少癌症患者的毒性，但相对昂贵且未经证实。评估生活质量 (QOL) 和患者报告的结果 (PRO) 对于确立 PBT 在肿瘤治疗中的“价值”至关重要。本系统评价的目的是评估接受 PBT 治疗的患者的生活质量和 PRO。